medical device investing

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which…
Read More...

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both…
Read More...

The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s…
Read More...

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing…
Read More...

"Real-world evidence on chronic lesion formation and durability is critical as use of PFA for the treatment of Afib…
Read More...

Financial Results Delivered record revenues of $95,573, an increase of $5,668 or 6% over the same period in prior…
Read More...

Second quarter revenue was $10.54 billion. Second quarter GAAP diluted earnings per share (EPS) increased 15% to…
Read More...

Second quarter revenue was $10.54 billion. Second quarter GAAP diluted earnings per share (EPS) increased 15% to…
Read More...

“With the launch of ChatGPT late in 2022, the true scale of its disruptive potential was more realized across the…
Read More...